
    
      This is an observational, longitudinal, multicenter study, including patients with rheumatic
      diseases who have been vaccinated for COVID-19 in Argentine or any country. Patients will be
      followed for 12 months and two evaluations will be performed, one at baseline and the other
      after the follow-up time is completed.

      The aim of this registry is to evaluate the efficacy and safety of the SARS-CoV-2 vaccines in
      patients with rheumatic diseases.
    
  